ELI-RO Symposium 2026

Pathways towards laser-neutron-induced radiplogic production and enhancement of FDA approved 177-Lu-based prostate cancer therapies supported by in-vitron essays (LaLuThe)

4 Nov 2026, 15:50

25m

IFA/9-905 (IFA)

Call 2024-2027: Project presentations: scientific progress and perspectives (Public Session)

Speaker

Dr Klaus SPOHR (IFIN-HH)

Description

15' presentation + 10' discussion